{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/97592"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/97592","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Production of 1-butanol and butanol isomers by metabolically engineered Clostridium beijerinckii and Saccharomyces cerevisiae","abstract":"The overall goal of my thesis research is to produce four-carbon alcohols such as 1-butanol and 2,3-butanediol, and isobutanol as advanced biofuels and chemicals from microorganisms through metabolic engineering, systems biology, and synthetic biology approaches. Biobutanol is an attractive renewable biofuel and intermediate chemical that has been produced from the ABE (acetone-butanol-ethanol) fermentation by solventogenic clostridia such as Clostridium beijerinckii. Although the ABE fermentation is considered as a promising process for butanol production, current drawbacks in the ABE fermentation include low titer, yield, and productivity of solvent production that needs to be improved to achieve an economically viable process. Therefore, the first goal of my thesis study was to improve the ABE fermentation by C. beijerinckii for production of butanol and its derivatives. This first objective involved four approaches. First, optimization of ABE fermentation condition was conducted to maximize butanol production in a small-scale standard platform. Second, product diversification in the ABE fermentation producing butyl esters was carried out through simultaneous ABE fermentation, condensation, and extraction to compensate the low yield of butanol. Third, oxygen-independent fluorescence reporter protein (FbFP) was employed for evaluating protein expression in C. beijerinckii under strict anaerobic conditions. With the FbFP reporter, screening of mutant, analysis of cell population, and metabolic engineering of C. beijerinckii were achieved. Lastly, evolutionary engineering of C. beijerinckii was performed to increase cell growth on lignocellulosic hydrolysate which is a potential feedstock for industrial butanol production. The second goal of my thesis study was to produce butanol isomers including 2,3-butanediol (2,3-BD) and isobutanol by industrial yeast S. cerevisiae strain. For this purpose, evolutionary engineering and metabolic engineering of pyruvate decarboxylase (Pdc)-negative S. cerevisiae were performed to increase the production of butanol isomers by eliminating ethanol production. The metabolically engineered Pdc-negative S. cerevisiae containing heterologous 2,3-BD biosynthetic pathway successfully produced 2,3-BD at high titer, yield and productivity without ethanol production. Isobutanol production was also significantly increased through identification of metabolic limitations and optimization of metabolic pathways in the recombinant Pdc-negative S. cerevisiae harboring a cytosolic isobutanol biosynthetic pathway. Overall, this study has broad implications for the sustainable biological production of higher-chain alcohols as advanced biofuels and chemicals which can replace the use of fossil fuel and petroleum. Moreover, findings and tools obtained in this study can be applied to synthetic biology and metabolic engineering of other solventogenic clostridia and yeast strains toward increased production of value-added bioproducts.","abstract_html":"The overall goal of my thesis research is to produce four-carbon alcohols such as 1-butanol and 2,3-butanediol, and isobutanol as advanced biofuels and chemicals from microorganisms through metabolic engineering, systems biology, and synthetic biology approaches. Biobutanol is an attractive renewable biofuel and intermediate chemical that has been produced from the ABE (acetone-butanol-ethanol) fermentation by solventogenic clostridia such as Clostridium beijerinckii. Although the ABE fermentation is considered as a promising process for butanol production, current drawbacks in the ABE fermentation include low titer, yield, and productivity of solvent production that needs to be improved to achieve an economically viable process. Therefore, the first goal of my thesis study was to improve the ABE fermentation by C. beijerinckii for production of butanol and its derivatives. This first objective involved four approaches. First, optimization of ABE fermentation condition was conducted to maximize butanol production in a small-scale standard platform. Second, product diversification in the ABE fermentation producing butyl esters was carried out through simultaneous ABE fermentation, condensation, and extraction to compensate the low yield of butanol. Third, oxygen-independent fluorescence reporter protein (FbFP) was employed for evaluating protein expression in C. beijerinckii under strict anaerobic conditions. With the FbFP reporter, screening of mutant, analysis of cell population, and metabolic engineering of C. beijerinckii were achieved. Lastly, evolutionary engineering of C. beijerinckii was performed to increase cell growth on lignocellulosic hydrolysate which is a potential feedstock for industrial butanol production. The second goal of my thesis study was to produce butanol isomers including 2,3-butanediol (2,3-BD) and isobutanol by industrial yeast S. cerevisiae strain. For this purpose, evolutionary engineering and metabolic engineering of pyruvate decarboxylase (Pdc)-negative S. cerevisiae were performed to increase the production of butanol isomers by eliminating ethanol production. The metabolically engineered Pdc-negative S. cerevisiae containing heterologous 2,3-BD biosynthetic pathway successfully produced 2,3-BD at high titer, yield and productivity without ethanol production. Isobutanol production was also significantly increased through identification of metabolic limitations and optimization of metabolic pathways in the recombinant Pdc-negative S. cerevisiae harboring a cytosolic isobutanol biosynthetic pathway. Overall, this study has broad implications for the sustainable biological production of higher-chain alcohols as advanced biofuels and chemicals which can replace the use of fossil fuel and petroleum. Moreover, findings and tools obtained in this study can be applied to synthetic biology and metabolic engineering of other solventogenic clostridia and yeast strains toward increased production of value-added bioproducts.","abstract_has_math":false,"creators":["Seo, Seungoh"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Food Science & Human Nutrition","degree_department":null,"school":null,"contributors":["Blaschek, Hans P.","Jin, Yong-Su","Miller, Michael J.","Lu, Ting"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2017,"date_issued":"2017-08-10T19:52:06Z","date_published":"2017-08-10T19:52:06Z","updated_at":"2026-07-22T22:24:34Z","subjects":["Butanol","Clostridium beijerinckii","Saccharomyces cerevisiae","Metabolic engineering"],"languages":["en"],"rights":["Copyright 2017 Seungoh Seo"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/2142/97592","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Blaschek, Hans P.","Jin, Yong-Su","Miller, Michael J.","Lu, Ting"]},{"key":"dc:creator","label":"Author","values":["Seo, Seungoh"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2017-08-10T19:52:06Z","2019-08-11T09:15:32Z","2017-04-20","2017-05"]},{"key":"dc:type","label":"Dc Type","values":["text"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Food Science & Human Nutrition"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Butanol","Clostridium beijerinckii","Saccharomyces cerevisiae","Metabolic engineering"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright 2017 Seungoh Seo"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/97592"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["The overall goal of my thesis research is to produce four-carbon alcohols such as 1-butanol and 2,3-butanediol, and isobutanol as advanced biofuels and chemicals from microorganisms through metabolic engineering, systems biology, and synthetic biology approaches. Biobutanol is an attractive renewable biofuel and intermediate chemical that has been produced from the ABE (acetone-butanol-ethanol) fermentation by solventogenic clostridia such as Clostridium beijerinckii. Although the ABE fermentation is considered as a promising process for butanol production, current drawbacks in the ABE fermentation include low titer, yield, and productivity of solvent production that needs to be improved to achieve an economically viable process. Therefore, the first goal of my thesis study was to improve the ABE fermentation by C. beijerinckii for production of butanol and its derivatives. This first objective involved four approaches. First, optimization of ABE fermentation condition was conducted to maximize butanol production in a small-scale standard platform. Second, product diversification in the ABE fermentation producing butyl esters was carried out through simultaneous ABE fermentation, condensation, and extraction to compensate the low yield of butanol. Third, oxygen-independent fluorescence reporter protein (FbFP) was employed for evaluating protein expression in C. beijerinckii under strict anaerobic conditions. With the FbFP reporter, screening of mutant, analysis of cell population, and metabolic engineering of C. beijerinckii were achieved. Lastly, evolutionary engineering of C. beijerinckii was performed to increase cell growth on lignocellulosic hydrolysate which is a potential feedstock for industrial butanol production. The second goal of my thesis study was to produce butanol isomers including 2,3-butanediol (2,3-BD) and isobutanol by industrial yeast S. cerevisiae strain. For this purpose, evolutionary engineering and metabolic engineering of pyruvate decarboxylase (Pdc)-negative S. cerevisiae were performed to increase the production of butanol isomers by eliminating ethanol production. The metabolically engineered Pdc-negative S. cerevisiae containing heterologous 2,3-BD biosynthetic pathway successfully produced 2,3-BD at high titer, yield and productivity without ethanol production. Isobutanol production was also significantly increased through identification of metabolic limitations and optimization of metabolic pathways in the recombinant Pdc-negative S. cerevisiae harboring a cytosolic isobutanol biosynthetic pathway. Overall, this study has broad implications for the sustainable biological production of higher-chain alcohols as advanced biofuels and chemicals which can replace the use of fossil fuel and petroleum. Moreover, findings and tools obtained in this study can be applied to synthetic biology and metabolic engineering of other solventogenic clostridia and yeast strains toward increased production of value-added bioproducts.","Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2019-05-01","The student, Seungoh Seo, accepted the attached license on 2017-04-18 at 10:57.","The student, Seungoh Seo, submitted this Dissertation for approval on 2017-04-18 at 13:29.","This Dissertation was approved for publication on 2017-04-20 at 14:04.","DSpace SAF Submission Ingestion Package generated from Vireo submission #10844 on 2017-08-10 at 14:31:10","Made available in DSpace on 2017-08-10T19:52:06Z (GMT). No. of bitstreams: 3 SEO-DISSERTATION-2017.pdf: 7417512 bytes, checksum: 58a16d6200db116d6d09d70bdc205db2 (MD5) LICENSE.txt: 4208 bytes, checksum: cf7717db86b31c5a22b7f2238d3cc462 (MD5) RightsLink_Printable_License_BB_Seungoh_Seo.pdf: 167885 bytes, checksum: 3c3ebbfae9942429682c858ec7e5c759 (MD5) Previous issue date: 2017-04-20","Embargo set by: Colleen Fallaw for item 102645 Lift date: 2019-08-10T21:25:30Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Limited Restriction Lifted for Item 102645 on 2019-08-11T09:15:32Z."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Production of 1-butanol and butanol isomers by metabolically engineered Clostridium beijerinckii and Saccharomyces cerevisiae"]}]}],"canonical_facts":{"dc:contributor":["Blaschek, Hans P.","Jin, Yong-Su","Miller, Michael J.","Lu, Ting"],"dc:creator":["Seo, Seungoh"],"dc:date":["2017-08-10T19:52:06Z","2019-08-11T09:15:32Z","2017-04-20","2017-05"],"dc:description":["The overall goal of my thesis research is to produce four-carbon alcohols such as 1-butanol and 2,3-butanediol, and isobutanol as advanced biofuels and chemicals from microorganisms through metabolic engineering, systems biology, and synthetic biology approaches. Biobutanol is an attractive renewable biofuel and intermediate chemical that has been produced from the ABE (acetone-butanol-ethanol) fermentation by solventogenic clostridia such as Clostridium beijerinckii. Although the ABE fermentation is considered as a promising process for butanol production, current drawbacks in the ABE fermentation include low titer, yield, and productivity of solvent production that needs to be improved to achieve an economically viable process. Therefore, the first goal of my thesis study was to improve the ABE fermentation by C. beijerinckii for production of butanol and its derivatives. This first objective involved four approaches. First, optimization of ABE fermentation condition was conducted to maximize butanol production in a small-scale standard platform. Second, product diversification in the ABE fermentation producing butyl esters was carried out through simultaneous ABE fermentation, condensation, and extraction to compensate the low yield of butanol. Third, oxygen-independent fluorescence reporter protein (FbFP) was employed for evaluating protein expression in C. beijerinckii under strict anaerobic conditions. With the FbFP reporter, screening of mutant, analysis of cell population, and metabolic engineering of C. beijerinckii were achieved. Lastly, evolutionary engineering of C. beijerinckii was performed to increase cell growth on lignocellulosic hydrolysate which is a potential feedstock for industrial butanol production. The second goal of my thesis study was to produce butanol isomers including 2,3-butanediol (2,3-BD) and isobutanol by industrial yeast S. cerevisiae strain. For this purpose, evolutionary engineering and metabolic engineering of pyruvate decarboxylase (Pdc)-negative S. cerevisiae were performed to increase the production of butanol isomers by eliminating ethanol production. The metabolically engineered Pdc-negative S. cerevisiae containing heterologous 2,3-BD biosynthetic pathway successfully produced 2,3-BD at high titer, yield and productivity without ethanol production. Isobutanol production was also significantly increased through identification of metabolic limitations and optimization of metabolic pathways in the recombinant Pdc-negative S. cerevisiae harboring a cytosolic isobutanol biosynthetic pathway. Overall, this study has broad implications for the sustainable biological production of higher-chain alcohols as advanced biofuels and chemicals which can replace the use of fossil fuel and petroleum. Moreover, findings and tools obtained in this study can be applied to synthetic biology and metabolic engineering of other solventogenic clostridia and yeast strains toward increased production of value-added bioproducts.","Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2019-05-01","The student, Seungoh Seo, accepted the attached license on 2017-04-18 at 10:57.","The student, Seungoh Seo, submitted this Dissertation for approval on 2017-04-18 at 13:29.","This Dissertation was approved for publication on 2017-04-20 at 14:04.","DSpace SAF Submission Ingestion Package generated from Vireo submission #10844 on 2017-08-10 at 14:31:10","Made available in DSpace on 2017-08-10T19:52:06Z (GMT). No. of bitstreams: 3 SEO-DISSERTATION-2017.pdf: 7417512 bytes, checksum: 58a16d6200db116d6d09d70bdc205db2 (MD5) LICENSE.txt: 4208 bytes, checksum: cf7717db86b31c5a22b7f2238d3cc462 (MD5) RightsLink_Printable_License_BB_Seungoh_Seo.pdf: 167885 bytes, checksum: 3c3ebbfae9942429682c858ec7e5c759 (MD5) Previous issue date: 2017-04-20","Embargo set by: Colleen Fallaw for item 102645 Lift date: 2019-08-10T21:25:30Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Limited Restriction Lifted for Item 102645 on 2019-08-11T09:15:32Z."],"dc:format":["application/pdf"],"dc:identifier":["http://hdl.handle.net/2142/97592"],"dc:language":["en"],"dc:rights":["Copyright 2017 Seungoh Seo"],"dc:subject":["Butanol","Clostridium beijerinckii","Saccharomyces cerevisiae","Metabolic engineering"],"dc:title":["Production of 1-butanol and butanol isomers by metabolically engineered Clostridium beijerinckii and Saccharomyces cerevisiae"],"dc:type":["text"],"thesis:degree_discipline":["Food Science & Human Nutrition"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:24:34Z"}